250 related articles for article (PubMed ID: 1831015)
1. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.
Larijani GE; Gratz I; Afshar M; Minassian S
Anesth Analg; 1991 Sep; 73(3):246-9. PubMed ID: 1831015
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ondansetron for prevention of postoperative nausea and vomiting after outpatient ear surgery under local anesthesia.
Ku PK; Tong MC; Lo P; van Hasselt CA
Am J Otol; 2000 Jan; 21(1):24-7. PubMed ID: 10651430
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.
Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL
N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807
[TBL] [Abstract][Full Text] [Related]
5. Ondansetron in the treatment of postoperative nausea and vomiting in ambulatory outpatients: a dose-comparative, stratified, multicentre study.
Du Pen S; Scuderi P; Wetchler B; Sung YF; Mingus M; Clayborn L; Leslie J; Talke P; Apfelbaum J; Sharifi-Azad S
Eur J Anaesthesiol Suppl; 1992 Nov; 6():55-62. PubMed ID: 1425626
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of postoperative nausea and vomiting with ondansetron in patients administered anti-neoplastic agents].
Morimoto Y; Nakamura M; Tamura T; Kunii T; Shimizu K; Miyauchi Y
Masui; 1996 Sep; 45(9):1096-9. PubMed ID: 8905945
[TBL] [Abstract][Full Text] [Related]
7. [Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo].
Ariyoshi Y; Ota K; Taguchi T; Furue H; Niitani H; Tsukagoshi S; Ikeda M; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2057-70. PubMed ID: 1417014
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
9. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
10. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
Argiriadou H; Papaziogas B; Pavlidis T; Parlapani A; Georgiou M; Papagiannopoulou P; Papaziogas T
Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of postoperative nausea and vomiting with ondansetron: a prospective, randomized, double-blind study in 90 patients].
Polati E; Finco G; Bartoloni A; Gottin L; Pinaroli AM; Zanoni L; Mazzetti C; Fontanive P
Minerva Anestesiol; 1995 Sep; 61(9):373-9. PubMed ID: 8919833
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.
Gan TJ; Apfel CC; Kovac A; Philip BK; Singla N; Minkowitz H; Habib AS; Knighton J; Carides AD; Zhang H; Horgan KJ; Evans JK; Lawson FC;
Anesth Analg; 2007 May; 104(5):1082-9, tables of contents. PubMed ID: 17456656
[TBL] [Abstract][Full Text] [Related]
14. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
15. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.
White PF; Tang J; Hamza MA; Ogunnaike B; Lo M; Wender RH; Naruse R; Sloninsky A; Kariger R; Cunneen S; Khalili T
Anesth Analg; 2006 May; 102(5):1387-93. PubMed ID: 16632815
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomized controlled trial.
Kyokong O; Somboonviboon W; Visalyaputra S; Pausawadi S; Saratan P; Vongvises P
J Med Assoc Thai; 1999 Feb; 82(2):173-7. PubMed ID: 10087725
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms].
Saur P; Mühr C; Kazmaier S; Neumann P; Buhre W
Anaesthesiol Reanim; 1996; 21(5):131-5. PubMed ID: 9044556
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blinded comparison of ondansetron, granisetron, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy.
Jain V; Mitra JK; Rath GP; Prabhakar H; Bithal PK; Dash HH
J Neurosurg Anesthesiol; 2009 Jul; 21(3):226-30. PubMed ID: 19543000
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of droperidol, metoclopramide, propofol, and ondansetron for the prevention of nausea and vomiting following middle ear surgery].
Karlidağ T; Kaygusuz I; Bestaş A; Keleş E; Demirbağ E; Yalçin S
Kulak Burun Bogaz Ihtis Derg; 2002; 9(5):331-6. PubMed ID: 12471278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
